Sellas Stock Jumps 15% As Retail Traders Watch Phase 3 Catalyst
June 6, 2026·about 3 hours ago·via Stocktwits

Sellas Life Sciences is drawing heavy retail attention as traders focus on a REGAL Phase 3 catalyst. The stock is up 15% on the buzz. The move centers on investor speculation around the trial milestone. Stocktwits is highlighting the surge in chatter. Read more about this...